Battelino T, Tehranchi R, Bailey T, Dovc K, et al. Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: results of a phase 3, randomized controlled trial. Pediatr Diabetes 2021 May 2. doi: 10.1111/pedi.13220.
PMID: 33934456